Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Adverse drug reaction (ADR) is one of the major causes of failure in drug development. Severe ADRs that go undetected until the post-marketing phase of a drug often lead to patient morbidity. Accurate prediction of potential ADRs is required in the entire life cycle of a drug, including early stages of drug design, different phases of clinical trials, and post-marketing surveillance. METHODS: Many studies have utilized either chemical structures or molecular pathways of the drugs to predict ADRs. Here, the authors propose a machine-learning-based approach for ADR prediction by integrating the phenotypic characteristics of a drug, including indications and other known ADRs, with the drug's chemical structures and biological properties, including protein targets and pathway information. A large-scale study was conducted to predict 1385 known ADRs of 832 approved drugs, and five machine-learning algorithms for this task were compared. RESULTS: This evaluation, based on a fivefold cross-validation, showed that the support vector machine algorithm outperformed the others. Of the three types of information, phenotypic data were the most informative for ADR prediction. When biological and phenotypic features were added to the baseline chemical information, the ADR prediction model achieved significant improvements in area under the curve (from 0.9054 to 0.9524), precision (from 43.37% to 66.17%), and recall (from 49.25% to 63.06%). Most importantly, the proposed model successfully predicted the ADRs associated with withdrawal of rofecoxib and cerivastatin. CONCLUSION: The results suggest that phenotypic information on drugs is valuable for ADR prediction. Moreover, they demonstrate that different models that combine chemical, biological, or phenotypic information can be built from approved drugs, and they have the potential to detect clinically important ADRs in both preclinical and post-marketing phases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIBSVM: A library for support vector machines
Chang, C.-C., & Lin, C.-J. (2011) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/1961189.1961199 · Cited by 40,918
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
SMOTE synthetic minority over-sampling technique
Chawla, N. V., Bowyer, K. W., Hall, L. O., & Kegelmeyer, W. P. (2002) · Journal of Artificial Intelligence Research · doi:10.1613/jair.953 · Cited by 32,865
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Libsvm : A library for support vector machines
Ferrari, V. (2008) · Medical Entomology and Zoology · Cited by 10,122
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
The unified medical language system (UMLS): integrating biomedical terminology
Bodenreider, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh061 · Cited by 4,356
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
A Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
PubChem: Integrated Platform of Small Molecules and Biological Activities
(2008) · Annual Reports in Computational Chemistry · doi:10.1016/s1574-1400(08)00012-1 · Cited by 1,263
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Szarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Yamanishi, Y., Kotera, M., Kanehisa, M., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 470
Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005
Moore, T. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1752 · Cited by 462
Pirmohamed, M., Breckenridge, A. M., Kitteringham, N. R., & Park, B. K. (1998) · BMJ · doi:10.1136/bmj.316.7140.1295 · Cited by 454
Whitebread, S., Hamon, J., Bojanic, D., & Urban, L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03632-9 · Cited by 404
LIBLINEAR: A Library for Large Linear Classification
FanRong-En, ChangKai-Wei, HsiehCho-Jui, WangXiang-Rui, & LinChih-Jen (2008) · Journal of Machine Learning Research · doi:10.5555/1390681.1442794 · Cited by 328
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327
An overview of the PubChem BioAssay resource
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp965 · Cited by 295
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
Xie, L., Li, J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000387 · Cited by 247
Predicting drug side-effect profiles: a chemical fragment-based approach
Pauwels, E., Stoven, V., & Yamanishi, Y. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-169 · Cited by 231
Tatonetti, N. P., Denny, J. C., Murphy, S. N., Fernald, G. H., Krishnan, G., Castro, V, Yue, P., Tsau, P. S., Kohane, I., Roden, D. M., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.83 · Cited by 201
Mining multi-item drug adverse effect associations in spontaneous reporting systems
Harpaz, R., Chase, H. S., & Friedman, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s9-s7 · Cited by 171
Mapping Adverse Drug Reactions in Chemical Space
Scheiber, J., Jenkins, J. L., Sukuru, S. C. K., Bender, A., Mikhailov, D., Milik, M., Azzaoui, K., Whitebread, S., Hamon, J., Urban, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801546k · Cited by 160
Analysis of drug-induced effect patterns to link structure and side effects of medicines
Fliri, A. F., Loging, W. T., Thadeio, P. F., & Volkmann, R. A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio747 · Cited by 158
Scheiber, J., Chen, B., Milik, M., Sukuru, S. C. K., Bender, A., Mikhailov, D., Whitebread, S., Hamon, J., Azzaoui, K., Urban, L., et al. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800344p · Cited by 152
PubChem as a Source of Polypharmacology
Chen, B., Wild, D., & Guha, R. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9001876 · Cited by 140
Predicting Adverse Drug Events Using Pharmacological Network Models
Cami, A., Arnold, A., Manzi, S., & Reis, B. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002774 · Cited by 131
Prediction of Adverse Drug Reactions Using Decision Tree Modeling
Hammann, F., Gutmann, H., Vogt, N., Helma, C., & Drewe, J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.248 · Cited by 109
Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System
Harpaz, R., Perez, H. R., Chase, H. S., Rabadán, R., Hripcsak, G. M., & Friedman, C. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.285 · Cited by 83
Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data
Pouliot, Y., Chiang, A. P., & Butte, A. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.81 · Cited by 80
An algorithm for mapping short reads to a dynamically changing genomic sequence
Flouri, T., Holub, J., Iliopoulos, C. S., & Pissis, S. P. (2010) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2010.5706551 · Cited by 74
Predicting drug side-effects by chemical systems biology
Tatonetti, N. P., Liu, T., & Altman, R. B. (2009) · Genome biology · doi:10.1186/gb-2009-10-9-238 · Cited by 71
False Discovery Rate Estimation for Frequentist Pharmacovigilance Signal Detection Methods
Ahmed, I., Dalmasso, C., Haramburu, F., Thiessard, F., Broët, P., & Tubert‐Bitter, P. (2009) · Biometrics · doi:10.1111/j.1541-0420.2009.01262.x · Cited by 70
Ahmed, I., Thiessard, F., Miremont‐Salamé, G., Bégaud, B., & Tubert‐Bitter, P. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.111 · Cited by 49
Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events
Chiang, A., & Butte, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.274 · Cited by 47
Side Effect Prediction Using Cooperative Pathways
Fukuzaki, M., Seki, M., Kashima, H., & Sese, J. (2009) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2009.26 · Cited by 40
Solving Imbalanced Classification Problems with Support Vector Machines.
Lessmann, S. (2004) · International Conference on Artificial Intelligence · Cited by 30
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“In addition, Liu et al. [141] integrated chemical, biological, phenotypic properties of drugs to predict ADR associated with it via machine learning analysis.”
BackgroundA review of approaches to identifying patient phenotype cohorts using electronic health records
Shivade, C., Raghavan, P., Fosler-Lussier, E., Embi, P. J., Elhadad, N., Johnson, S. B., & Lai, A. M. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001935 · Cited by 531
Yao, Z.-J., Dong, J., Che, Y.-J., Zhu, M.-F., Wen, M., Wang, N.-N., Wang, S., Lu, A.-P., & Cao, D.-S. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9915-2 · Cited by 514
Ozenne, B., Subtil, F., & Maucort-Boulch, D. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.02.010 · Cited by 379
Cheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
Self-citation
Metadata
- Authors
- Liu, M., Wu, Y., Chen, Y., Sun, J., Zhao, Z., Chen, X.-W., Matheny, M. E., & Xu, H.
- Venue
- Journal of the American Medical Informatics Association
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-01
- Volume
- 19
- Issue
- e1
- Pages
- e28-e35
- ISSN
- 1067-5027 (ISSN-L)
- 1527-974X
- OpenAlex
- W2136127280
- Cited by
- 289
- References
- 50
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.